We used mice to test our hypothesis that in response to viral invasion, stem cells may migrate into the heart and attenuate the effect of viral myocarditis. Male BALB/c mice were divided into three groups: mouse embryonic stem (ES) cell control, encephalomyocarditis virus (EMCV), and EMCV + ES cells. After administration of ES cells via tail vein, mice were immediately inoculated with EMCV. Mice were sacrificed at different days after EMCV inoculation. Mortality was recorded. Inflammatory cell infiltration and necrosis (major pathological changes of viral myocarditis) were evaluated by hematoxylin-eosin staining. ES cell migration and differentiation were identified by immunofluorescence. The survival rate in the EMCV + ES cell group (80%) was significantly increased (p < 0.05) over the EMCV-alone group (64%). Also, the incidence of inflammatory cell infiltration and myocardial lesions was lower in the EMCV + ES cell mice. Furthermore, the result of green fluorescent protein (GFP) and α-actinin analysis indicated that ES cells migrated into the heart and differentiated into myocytes after virus inoculation. In conclusion, ES cells significantly increased the survival of viral myocarditis mice and also decreased the necrosis and infiltration of inflammatory cells. These results demonstrated the ability of stem cells to mitigate the effects of viral infection on the heart and illustrated their potential therapeutic application to other mammalian species, including humans. 753 754 WANG ET AL.
INTRODUCTION
temic diseases, drugs, and toxins have been associated with the development of this disease. There is a consensus that viruses may be a predominant cause of myocar-Several studies suggest that stem cells can transdifferentiate into other cell types, including myocytes and ditis (6). For example, human immunodeficiency virus (HIV) has been detected in heart tissue from patients neurons (3, 11) , carrying significant implications for the possible clinical use of these cells. Some investigators with the acquired immunodeficiency syndrome (1,2). Hepatitis C is able to replicate in the human myocar-have demonstrated that after local transplantation, heart cells and myoblasts show significant potential to repair dium and may also be involved in the development of dilated cardiomyopathy (10, 12) . Other viral agents such infarcted myocardium and improve heart function (5, 14) . In addition, it has recently been demonstrated that bone as influenza A and B, polio, mumps, and rubella have been shown to cause myocarditis (6). marrow cells have the potential to regenerate infarcted myocardium (13) . Other studies have shown that human At present, there are no effective therapies for preventing or reversing the structural and functional changes bone marrow-derived angioblasts accelerate the neovascularization of ischemic myocardium and improve myo-that occur and may cause death or debility of approximately one third of patients with clinical manifestations cardial function (8).
Myocarditis is a multifaceted disease process involv-of myocarditis. We hypothesize that embryonic stem (ES) cells may be capable of responding to signals from ing viral infection, immune activation, and microvascular spasm (7, 14) . It is characterized by myocardial ne-areas of inflammation and necrosis in myocarditis by proliferating, migrating into, and restoring functionality crosis and inflammation in the acute stage, followed by myocardial fibrosis, calcification, cardiac dilatation, hy-of damaged areas. In the present study, mice were injected with mouse embryonic stem cells via tail vein and pertrophy, and heart failure in the chronic stage. Although the specific cause of myocarditis in any given patient immediately inoculated with encephalomyocarditis virus (EMCV). Morbidity, mortality, and histopathology were often remains unclear, a large variety of infections, sys-assessed to evaluate the effect of ES cells on viral myo-coincide with the acute phase (day 3), initial myocardial inflammation (day 7), peak inflammatory cell infiltration carditis.
(day 14), and the beginning of fibrosis and dilated car-MATERIALS AND METHODS diomyopathy (day 30).
Preparation of ES Cells
All animal experiments were performed in accor-The mouse ES cell line, ES-D3, was obtained from dance with National Institute of Health guidelines. Prothe American Type Culture Collection (ATCC, Manastocols were approved by the Animal Care and Use Comsas, VA) and maintained with the methods as previously mittee of Beth Israel Deaconess Medical Center and described (1). Briefly, ES-D3 cells were cultured in Dul-Harvard Medical School. becco's modified Eagle's medium (DMEM) on mitoti-Histopathology and Fluorescent Staining cally inactive mouse embryonic fibroblast feeder cells (ATCC). The medium was supplemented with 15% fetal At each designated day, four mice were randomly bovine serum, 0.1 mM β-mercaptoethanol (Sigma, St.
chosen for sacrifice. Heart, spleen, liver, lung, and kid-Louis, MO), and 10 3 U/ml of leukemia inhibitory factor ney were excised and embedded in tissue-freezing me-(LIF) conditioned medium (BRL, Gaithersburg, MD) to dium (Triangle Biomedical Sciences, Durham, NC) and suppress differentiation. Before cell transplantation, ES then frozen in liquid nitrogen. The tissues were then cells were transfected with enhanced green fluorescent cryostat sectioned to 5 µm thickness. Those sections protein (GFP), used to identify survival of transplanted were kept at −80°C until hematoxylin and eosin staining ES cells. A plasmid with hCMV IE promoter/enhancer for pathology scoring, or immunohistochemical analysis, diving GFP gene (5.7 kb) and GenePORTER TM transfecas described below. Several sections of each organ were tion reagent was obtained from Gene Therapy Systems scored blindly by experienced readers. For each myocar-Inc. (GTS Inc., San Diego, CA). An adequate amount of dial sample (dead mice did not undergo necropsy), histo-ES cells was plated in 100-mm dishes to obtain 50-60% logical evidence of myocarditis and inflammation was confluence on the day of transfection. Plasmid GFP DNA classified in terms of the degree of cellular infiltration (8 µg) was added to each dish with a calcium phosphate and myocardial cell necrosis and graded on a 5-point precipitation method. After 2 days of GFP transfection, scale ranging from 0 to 4+. A zero score indicated no or cultured ES cells were trypsinized and resuspended in questionable presence of lesions in each category. A 1+ Joklik modified medium (Sigma) with a density of 10 7 score described a limited focal distribution of myocarcells/ml for infusion. dial lesions. A score of 2+ to 3+ described intermediate severity with multiple lesions, whereas a 4+ score de-Virus Preparation and Inoculation of Mice scribed the presence of coalescent and extensive lesions The M variant of encephalomyocarditis virus (EMCV) over the entire examined heart tissue. (ATCC) was used in this study. We selected the murine Different frozen sections were stained immunohisto-EMCV model of myocarditis for these studies because chemically with a mouse monoclonal anti-GFP antibody it is well established in our laboratory (9,18). Viral stock (Zymed, San Francisco, CA) and monoclonal anti-αwas prepared as follows: human amnion (FL) cell monoactinin clone EA-53 antibody (Sigma). After washing layers were infected with EMCV and harvested when with PBS, sections were incubated with a goat anticytopathic effects were completed. The viral titers were mouse-conjugated fluorescent IgG antibody for GFP determined by plaque formation on a FL cell monolayer.
(Pierce Chemical Co., Rockford, IL) or goat anti-mouse The viral stock was stored at −80°C until use. Mice were IgG1 conjugated to TRITC for α-actinin (Santa Cruz inoculated IP with 140 plaque-forming units (0.1 ml) of Biotechnology Inc., Santa Cruz, CA). After the employ-EMCV diluted in Eagle's minimum essential medium. ment of the GFP and α-actinin labeling, sections were Experimental Protocol counterstained with 4′6′-diamidino-2-phenylindole (DAPI). Finally, fluorescent staining of GFP, α-actinin, and A total of 100 4-week-old BALB/c male mice were DAPI was detected and photographed under confocal obtained from the Charles River Laboratories (Wilmingmicroscopy. ton, MA). ES cells were administered via tail vein (1 × 10 7 cells per mouse). The mice were immediately inocu-Statistical Analysis lated with EMCV after the administration of ES cells. Animals were randomly divided into three groups: ES Results are presented as mean ± SD. Survival of mice was analyzed by the Kaplan-Meier method. Comparison cells (n = 30), EMCV (n = 35), and EMCV + ES (n = 35). The day of virus inoculation was defined as day 0.
within and between groups was performed using oneway ANOVA. Post hoc comparison of individual groups Animals were sacrificed at 3, 7, 14, and 30 days following virus inoculation to determine pathological changes was done using Newman-Keul subgroup analysis. A value of p < 0.05 was considered significant. at each stage of infection. These times were chosen to
RESULTS
into myocytes, because the muscle-specific protein, αactinin, was detected in GFP-stained cells.
Morbidity and Mortality
Infection with EMCV produced similar pathological DISCUSSION changes to those reported previously by our group and Administration of mouse ES cells significantly deothers (9,18) in this murine viral myocarditis model. In creased the mortality of viral myocarditis. This is the brief, 3 days after virus inoculation, the mice appeared first demonstration of a protective effect against viral ill, and some developed coat ruffling, weakness, and irrimyocarditis by ES cell transplantation. Our results may tability. Some mice developed a paralysis of the hind be summarized as follows: 1) ES cells significantly inlegs. Mortality among the virus control mice was 36%.
creased the survival of mice with myocarditis; 2) inva-However, in the ES cell group, the mortality of myocarsion of the virus stimulated the migration of ES cells ditis mice was 20% (p < 0.05 compared with the uninto the myocardium; and 3) ES cells differentiated into treated group) ( Fig. 1) . myocytes in the myocarditic heart.
Recently, studies have demonstrated improvement of Histological Examination myocardial function after cell transplantation. Those stud-On day 3, there were no gross pathological changes ies found that after transplantation, cells might differenin myocardium of viral-infected mice. On days 7, 14, tiate into new myocytes, endothelial cells, and smooth and 30, myocyte necrosis and accompanying inflammamuscle cells in infarcted myocardium (4, 5, 14) . Almost tion had become extensive, confluent in some areas and all of these studies were focused on the regional repair multifocal in others (Fig. 2) . In the ES cell-treated group, of infarcted myocardium. However, the effect of ES cells pathological changes were ameliorated among myocaron global heart injury is unclear, especially in viral myoditic animals. The histopathological scores of necrosis carditis and during the subsequent pathogenesis of diand inflammatory cell infiltration were significantly lated cardiomyopathy with heart failure. Regeneration of lower in the ES cell-treated groups in comparison with organ-specific new cells may be one of the major mechthose of untreated animals (Table 1) .
anisms used by stem cells to repair damaged tissue and ES Cells Migrate Into the Heart improve function. In our present study, we observed that ES cells, which were administered via tail vein, signifi- Figure 3a shows there was minimal green fluorescence in myocardium from uninfected mice treated with cantly decreased the mortality, necrosis, and infiltration of inflammatory cells. The GFP and α-actinin fluores-ES cells transfected with cDNA for GFP. In contrast, Figure 3b indicates that there was significant green fluo-cence studies indicated that ES cells migrated into the myocarditic heart and differentiated into new myocytes. rescence 14 days after administration of ES cells in myocardium from viral-infected mice, indicating that
We conclude that differentiation of myocytes may be one of the major reasons that ES cells decrease the ne-ES cells homed to the hearts of animals with myocarditis. Figure 3e -h indicates that ES cells can differentiate crosis, inflammation, and mortality of viral myocarditis. 3.5 ± 0.2 1.9 ± 0.2 1.8 ± 0.2 2.8 ± 0.1 2.0 ± 0.2 Virus + ES cells 1.5 ± 0.2* 2.7 ± 0.1* 1.1 ± 0.1* 1.2 ± 0.2* 1.9 ± .02* 1.2 ± 0.1* Histological scoring of hearts ranged from 0 to 4 + in each of the categories of inflammation and necrosis. Data are expressed as mean ± SEM (n = 4 at each time point). *p < 0.05 compared with untreated group.
Alternatively, hybridization of stem cells with native myopathy, terminal failure, and death. The principal pathogenic mechanisms probably include direct viral cells has been reported to occur in vitro in culture (17, 19, 20) . Although this has not been reported to occur in tissue damage and immunocyte-mediated cellular damage critical for the progression of myocarditis to dilated vivo after cell transplantation, such alternative interpretations of our data must be kept in mind.
cardiomyopathy and heart failure (7, 16) . Direct virusinduced cytotoxicity occurring within 3 days after infec-Current theories about myocarditis suggest that a three-step process occurs (7, 16) . The process begins tion exhibits focal necrotic myofibers in the absence of an inflammatory cell infiltrate (7). During this patholog-with an acute phase 0-3 days after viral infection. There is an initial viral infection of genetically susceptible host ical period, positive GFP staining was detectable in the myocardium, but there was no significant pathological myocytes that can lead to early pathological evidence of myocardial damage. After viral invasion of the myocar-difference between the treated and untreated groups. We concluded that ES cells do not affect this phase. In this dium, cell-mediated immunity activates the subacute phase of myocardial and endothelial damage. Finally, a experimental model, the immune T-cell infiltration peaks on days 7-14 after virus inoculation, coinciding chronic phase is characterized by slow myocyte loss and myocardial fibrosis, which progresses to dilated cardio-with the most severe acute pathological damage in the from uninfected mice treated with ES cells transfected Itesch, S. Neovasularization of ischemic myocardium by with cDNA for GFP. These cells may infiltrate through human bone-marrow-derived angioblasts prevents cardiovessels into the myocardium. The detailed mechanism myocyte apoptosis, reduces remodeling and improves carneeds to be studied further. We propose that ES cells may diac function. Nat. Med. 7:430-436; 2001. 9 . Matsumori, A.; Crumpacker, C. S.; Abelmann, W. H. Pre-have two ways to rescue inflammatory or damaged tissue: vention of viral myocarditis with recombinant human leu-1) differentiation into new myocytes to replace dead or kocyte interferon alpha A/D in a murine model. J. Am. damaged cells, and 2) delivery of pharmacologically ac- Coll. Cardiol. 9:1320 -1325 1987. tive substances to affected areas of the heart. which stimulates stem cells to migrate toward the myo-McKercher, S. R. Turning blood into brain: Cells bearing cardium. However, the determination of the detailed neuronal antigens generated in vivo from bone marrow. mechanism of cellular homing requires further study. Science 290:1779 Science 290: -1782 Our data in an animal model may be important with 12. Okabe, M.; Fukuda, K.; Arakawa, K.; Kikuchi, M.
Chronic variation of myocarditis associated with hepatitis regard to the therapy of viral myocarditis among the hu-
